Chonluten

Chonluten is a Khavinson bioregulator tripeptide studied for bronchopulmonary tissue support and inflammatory-pathway modulation.

Profile · 01

Overview

Chonluten is a short bioregulatory tripeptide with the sequence Glu-Asp-Gly, discussed in the Khavinson peptide framework for bronchopulmonary tissue support and inflammatory regulation. It is not FDA-approved for any indication.

Most support comes from cell-culture and preclinical work rather than large human clinical trials. This page presents the staged once-daily subcutaneous protocol from the supplied markdown source as educational content.

At a Glance

Goal

Support bronchopulmonary tissue regulation and inflammatory-pathway balance

Protocol

Suggested daily titration approach starting low and increasing every one to two weeks.

Reconstitute

Add 3.0 mL bacteriostatic water to a 20 mg vial for about 6.67 mg/mL concentration

Typical daily range

250 mcg to 4 mg once daily

Start

250 mcg daily for Weeks 1-2

Target

2-4 mg daily by Weeks 9-16

Frequency

Once per day (subcutaneous)

Cycle Length

8-12 weeks; optional extension to 16 weeks

Timing

Any consistent time; rotate injection sites

Route

Subcutaneous

Cycle

8-12 weeks on, 4 weeks off

Inject once daily subcutaneously using the 3.0 mL dilution to keep measurements practical. Very low starting volumes may be easier to read on 30-unit or 50-unit syringes. Evidence is primarily preclinical and cell-based rather than trial-driven.

Dose progression

Weeks 1-2

250 mcg (0.25 mg) · 4 units (0.04 mL)

Weeks 3-4

500 mcg (0.50 mg) · 8 units (0.08 mL)

Weeks 5-6

1 mg · 15 units (0.15 mL)

Weeks 7-8

1.5 mg · 23 units (0.23 mL)

Weeks 9-10

2 mg · 30 units (0.30 mL)

Weeks 11-12

3 mg · 45 units (0.45 mL)

Weeks 13-16

4 mg · 60 units (0.60 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Chonluten works.

Chonluten is presented as a short Khavinson bioregulator peptide studied in bronchopulmonary and monocyte/macrophage cell models. The literature discussed in the source centers on inflammatory-pathway modulation, proliferative signaling, and tissue-homeostasis effects.

The proposed mechanism often includes selective DNA-sequence interaction or gene-expression modulation, but that framework remains more theoretical and preclinical than broadly validated in large human trials.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support bronchopulmonary tissue regulation based on preclinical bioregulator literature

Cell-based work suggests modulation of inflammatory and proliferative pathways

Short peptides in this class are generally described as well tolerated in preclinical settings

Mild injection-site reactions such as redness or itching may occur

Large human clinical trials are not available

Long-term human efficacy and safety remain uncertain

Science · 03

Caution

Use caution in active cancer or significant cancer history because proliferative signaling is part of the theoretical mechanism discussion

Not recommended during pregnancy or breastfeeding because safety data is insufficient

Use caution in autoimmune respiratory conditions or other complex inflammatory disease states

Consult a qualified healthcare provider before use if you have chronic respiratory or medical conditions

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

N-Acetyl Cysteine (NAC)

Supports glutathione production and respiratory antioxidant defense.

Vitamin C

Supports antioxidant balance and mucosal integrity.

Vitamin D

Relevant to immune modulation and respiratory health.

Zinc

Supports epithelial barrier integrity and immune function.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain a diet rich in antioxidants to support respiratory tissue health

Use regular aerobic activity appropriate to your baseline condition

Prioritize sleep and stress management to support immune regulation

Avoid smoking and limit exposure to respiratory irritants and pollutants

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Respiratory function - track breathing ease and exercise tolerance
Inflammatory symptoms - monitor coughing, chest tightness, or mucus trends
Energy and exercise tolerance - useful for broader recovery tracking
Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CRP (C-Reactive Protein)

General inflammation marker for baseline and follow-up.

CBC with differential

Useful for immune and inflammatory context.

CMP (Comprehensive Metabolic Panel)

Assesses liver and kidney function during peptide use.

IgE

Potentially relevant where allergic or atopic respiratory issues are part of the picture.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 20 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry

Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue

Do not aspirate for subcutaneous injections; inject slowly and steadily

Rotate sites systematically across the abdomen, thighs, and upper arms

Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely

Very low starting volumes may be easier to read on 30-unit or 50-unit syringes

Document dose, site rotation, and respiratory symptom trends for consistency

Human evidence is limited and remains largely preclinical

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

International Journal of Molecular Sciences
Khavinson-related cell-model work on inflammatory and proliferative peptide effects.
https://www.mdpi.com/journal/ijms
Biomedicines
Peptide delivery and bioregulatory peptide context.
https://www.mdpi.com/journal/biomedicines
Signal Transduction and Targeted Therapy
Therapeutic peptides review.
https://www.nature.com/articles/s41392-022-00904-4
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
WHO (NCBI Bookshelf)
Injection-safety guidance for subcutaneous administration.
https://www.ncbi.nlm.nih.gov/books/NBK390474/